Abstract
The administration of phage therapy for aquaculture disease has been anticipated by the researchers over a decade as an effective and an alternative control mechanism, though the application of phages as a disease control agent in aquaculture projects various beneficial aspects, critical limitations, and negative influence on production. This present scenario made a pressure to review the possible disclosure of phage therapy with its critical boundaries and limiting influences towards the disease control management of aquaculture (fish, shrimps, lobsters, bivalve mollusks, etc.). The phage therapy has proven its efficacy as a biocontrol agent towards aquaculture disease, although the sustainability of the phage therapy needs further investigation on the following: commercial application, formulation of bacteriophage for layman usage, and development of protocol for various diseases with consistent results. The marginal space existing between the inventors and the end user must be fulfilled by the awareness program and the government policies. The administration of the phage therapy could be effective for long-term safety and negatively influence the development of multidrug-resistant bacteria pathogens in the future.
Similar content being viewed by others
References
Al-Sum AB, Al-Dhabi NA (2014) Isolation of bacteriophage from Mentha species in Riyadh, Saudi Arabia. J Pure Appl Micro 8(2):945–949
Almeida GMF, Mäkelä K, Laanto E, Pulkkinen J, Vielma J, Sundberg L-R (2019) The Fate of Bacteriophages in Recirculating Aquaculture Systems (RAS)—Towards Developing Phage Therapy for RAS. Antibiotics 8 (4):192
Austin B, Zhang XH (2006) Vibrio harveyi: a significant pathogen of marine vertebrates and invertebrates. Lett Appl Microbiol 43(2):119–124
Azam AH, Tanji Y (2019) Bacteriophage-host arm race: an update on the mechanism of phage resistance in bacteria and revenge of the phage with the perspective for phage therapy. Appl Micro Biotech 103:2121–2131
Berthe FCJ (ed) (2005) Diseases in mollusc hatcheries and their paradox in health management, Fish Health Section. Asian Fisheries Society, Manila
Bradley DE (1967) Ultrastructure of bacteriophage and bacteriocins. Bact Rev 31:230–314
Chaikeeratisak V, Khanna K, Nguyen KT, Sugie J., Egan ME, Erb ML, Vavilina A, Nonejuie P, Nieweglowska E, Pogliano K, Agard DA, Villa E, Pogliano J (2019) Viral capsid trafficking along treadmilling tubulin filaments in Bacteria. Cell 177: 1771–1780
Chen L, Yuan S, Liu Q, Mai G, Yang J, Deng D, Zhang B, Liu C, Ma Y (2018) In vitro design and evaluation of phage cocktails against Aeromonas salmonicida. Front Microbiol 9:1476. https://doi.org/10.3389/fmicb.2018.01476
Citorik RJ, Mimee M, Lu TK (2014) Bacteriophage-based synthetic biology for the study of infectious diseases. Curr Opi Micro 19:59–69
Crothers-Stomps C, Hoj L, Bourne DG, Hall MR, Owens L (2010) Isolation of lytic bacteriophage against Vibrio harveyi. J Appl Microbiol 108(5): 1744–1750, 2010
Daw MA, Falkiner FR (1996) Bacteriocins: nature, function and structure. Micron 27:467–479
Drulis-Kawa Z, Majkowska-Skrobek G, Maciejewska B (2015) Bacteriophages and phage-derived proteins – application approaches. Curr Med Chem 22(14):1757–1773
García R, Latz S, Romero J, Higuera G, García K and Bastías R (2019) Bacteriophage Production Models: An Overview. Front. Microbiol. 10: 1187
Hagens S, Offerhaus ML (2014) Bacteriophages – new weapons for food safety. Food Technol 62:46–54
Haq IU, Chaudhry WN, Akhtar MN, Andleeb S, Qadri I (2012) Bacteriophages and their implications on future biotechnology: a review. Virol J 9(9):1–8
Holmstrom K, Graslund S, Wahlstrom A, Poungshompoo S, Bengtsson BE, Kautsky N (2003) Antibiotic use in shrimp farming and implications for environmental impacts and human health. Int J Food Sci Technol 38(3):255–266
Imbeault S, Parent S, Lagace M, Uhland CF, Blais JF (2006) Using bacteriophages to prevent furunculosis caused by Aeromonas salmonicida in farmed Brook Trout. J Aquat Anim Health 18(3):203–214
Inal JM (2003) Phage therapy: a reappraisal of bacteriophages as antibiotics. Arch Immunol Ther Exp 51:237–244
Jun JW, Shin TH, Kim JH, Shin SP, Han JE, Heo GJ, De Zoysa M, Shin GW, Chai JY, Park SC. Bacteriophage therapy of a Vibrio parahaemolyticus infection caused by a multiple-antibiotic-resistant O3: K6 pandemic clinical strain. J Infect Dis. 2014;210:72–8
Jun J, Giri SS, Kim HJ, Yun SK, Chi C, Chai JY, Lee BC, Park SC (2016) Bacteriophage application to control the contaminated water with Shigella. Sci Rep 6:22636. https://doi.org/10.1038/srep22636
Jun JW, Han JE, Giri SS, Tang KFJ, Zhou X, Aranguren LF, Kim HJ, Yun S, Chi C, Kim SG, Park SC (2018) Phage application for the protection from acute hepatopancreatic necrosis disease (AHPND) in Penaeus vannamei. Ind J Micro 58:14–117
Kalatzis P, Castillo D, Katharios P, Middelboe M (2018) Bacteriophage Interactions with Marine Pathogenic Vibrios: Implications for Phage Therapy. Antibiotics 7 (1):15
Karunasagar I, Pai R, Malathi GR, Karunasagar I (1994) Mass mortality of Penaeus monodon larvae due to antibiotic resistant Vibrio harveyi infection. Aquaculture 128(3–4):203–209
Karunasagar I, Vinod MG, Kennedy B, Vijay A (2005) Biocontrol of bacterial pathogens in aquaculture with emphasis on phage therapy, In: Walker PJ, Lester RG, Bondad-Reantaso MG (ed) Diseases in Asian aquaculture V. Fish Health section, Asian Fisheries Society, Manila, pp 535–542
Karunasagar I, Shivu MM, Girisha SK, Krohne G (2007) Biocontrol of pathogens in shrimp hatcheries using bacteriophages. Aquaculture 268(1–4):288–292
Kiran GS, Priyadharshini S, Dobson A, Gnanamani E, Selvin J (2016). Degradation intermediates of polyhydroxy butyrate inhibits phenotypic expression of virulence factors and biofilm formation in luminescent Vibrio sp. PUGSK8. NPJ Biofilms and Microbiomes 2: 16002.
Kongari R, Rajaure M, Cahill J, Rasche E, Mijalis E, Berry J, Young R (2018) Phage spanins: diversity, topological dynamics and gene convergence. BMC Bioinformatics 15 19(1): 326
Laanto E, Bamford JKH, Ravantti JJ, Sundberg LR (2015) The use of phage FCL-2 as an alternative to chemotherapy against columnaris disease in aquaculture. Front Microbiol 6: 829. https://doi.org/10.3389/fmicb.2015.00829
Labrie SJ, Samson JE, Moineau S (2010) Bacteriophage resistance mechanisms. Nat Rev Microbiol 8:317–327
Lavilla-Pitogo CR, Baticados MCL, Cruz-Lacierda ER, .de la Pena LD (1990) Occurrence of luminous bacterial disease of Penaeus monodon larvae in the Philippines. Aquaculture 91(1–2): 1–13
Lehti TA, Pajunen MI, Skog MS, Finne J (2017) Internalization of a polysialic acid-binding Escherichia coli bacteriophage into eukaryotic neuroblastoma cells. Nat Commun 8(1915):1–12
Levin BR, Bull JJ (2004) Population and evolutionary dynamics of phage therapy. Nat Rev Microbiol 2:166–173
Loc-Carrillo C, Abedon ST (2011) Pros and cons of phage therapy. Bacteriophage 1(2):111–114
Ly-Chatain MH (2014) The factors affecting effectiveness of treatment in phages therapy. Front Microbiol 5(51):1–7
Manning AJ, Kuehn MJ (2011) Contribution of bacterial outer membrane vesicles to innate bacterial defense. BMC Microbiol 11:258
Matsuzaki S, Yasuda M, Nishikawa H, Kuroda M, Ujihara T, Shuin T, Shen Y, Jin Z, Fujimoto S, Nasimuzzaman MD, Wakiguchi H, Sugihara S, Sugiura T, Koda S, Muraoka A, Imai S (2003) Experimental protection of mice against lethal Staphylococcus aureus infection by novel bacteriophage phi MR11. J Infect Dis 187:613–624
Meaden S, Koskella B (2013) Exploring the risks of phage application in the environment. Front Microbiol 4:358
Mohammed-Ali MN, Jamalludeen NM (2015) Isolation and characterization of bacteriophage against methicillin resistant Staphylococcus aureus. J Med Microb Diagn 5: 213
Nakai T, Park SC (2002) Bacteriophage therapy of infectious diseases in aquaculture. Res Microbiol 153:13–18
Nakai T, Sugimoto R, Park KH, Matsuoka S, Mori K, Nishioka T, Maruyama K (1999) Protective effects of bacteriophage on experimental Lactococcus garvieae infection in yellowtail. Dis Aquat Org 37:33–41
Nobrega FL, Costa AR, Kluskens LD, Azeredo J (2015) Revisiting phage therapy: new applications for old resources. Trends Microbiol 23:185–191
Oliveira J, Castilho F, Cunha A, Pereira MJ (2012) Bacteriophage therapy as a bacterial control strategy in aquaculture. Aquacult Int 20:879–910
Oliveira H, Sao-Jose C, Azeredo J (2018) Phage derived peptidoglycan degrading enzymes: challenges and future prospects for in vivo therapy. Viruses 10(6):292
Ormala AM, Jalasvuori M (2013) Phage therapy: should bacterial resistance to phages be a concern, even in the long run? Bacteriophage 3:e24219
Parisien A, Allain B, Zhang J, Mandeville R, Lan CQ (2008) Novel alternatives to antibiotics: bacteriophages, bacterial cell wall hydrolases, and antimicrobial peptides. J Appl Micro 104:1–13
Park SC, Nakai T (2003) Bacteriophage control of Pseudomonas plecoglossicida infection in ayu Plecoglossus altivelis. Dis Aquat Org 53:33–39
Park KH, Matsuoka S, Nakai T, Muroga K (1997) A virulent bacteriophage of Lactococcus garvieae (formerly Enterococcus seriolicida) isolated from yellowtail Seriola quinqueradiata. Dis Aquat Org 29(2):145–149
Park KH, Kato H, Nakai T, Muroga K (1998) Phage typing of Lactococcus garvieae (formerly Enterococcus seriolicida) a pathogen of cultured yellowtail. Fish Sci 64:62–64
Park SC, Shimamura I, Fukunaga M , Mori KI, Nakai (2000) Isolation of bacteriophages specific to a fish pathogen, Pseudomonas plecoglossicida, as a candidate for disease control. Appl Environ Microbiol 66:1416–1422
Payne M (2007) Towards successful aquaculture of the tropical rock lobster, Panulirus ornatus: the microbiology of larval rearing, PhD Thesis, University of Queensland
Pelkonen S, Aalto J, Finne J (1992) Differential activities of bacteriophage depolymerase on bacterial polysaccharide: binding is essential but degradation is inhibitory in phage infection of K1-defective Escherichia coli. J Bacteriol 174:7757–7761
Pereira C, Silva YJ, Santos AL, Cunha Â, Gomes NCM, Almeida A (2011) Bacteriophages with Potential for Inactivation of Fish Pathogenic Bacteria: Survival, Host Specificity and Effect on Bacterial Community Structure. Marine Drugs 9 (11):2236–2255
Pereira C, Moreirinha C, Teles L, Rocha RJM, Calado R, Romalde JL, Nunes ML (2017) Adelaide Almeida, Application of phage therapy during bivalve depuration improves Escherichia coli decontamination. Food Microbiol 61: 102–112
Perreten V (2005) Resistance in the food chain and in bacteria from animals: relevance to human infections. In: White DG, Alekshun MN, McDermott PF (eds) Frontiers in antimicrobial resistance. American Society for Microbiology, Washington, DC, p 575
Rao BM, Lalitha KV (2015) Bacteriophages for aquaculture: Are they beneficial or inimical. Aquaculture 437:146-154
Richards GP (2014) Bacteriophage remediation of bacterial pathogens in aquaculture: a review of the technology. Bacteriophage 4(4): e975540 1-12
Rico A, Satapornvanit K, Haque MM, Min J, Nguyen PT, Telfer TC, van den Brink PJ, (2012) Use of chemicals and biological products in Asian aquaculture and their potential environmental risks: a critical review. Reviews in Aquaculture 4 (2):75-93
Selvin J, Lipton AP (2003). Leaching and residual kinetics of chloramphenicol incorporated medicated feed treated to juvenile black tiger shrimp Penaeus monodon Fabricious. Fish Technol 40: 13-17
Selvin J, Lipton AP (2004) Leaching and residual kinetics of oxytetracycline incorporated medicated feed treated to juvenile black tiger shrimp Penaeus monodon Fabricious. Fish Technol 41: 93-100
Ross A, Ward S, Hyman P (2016) More is better: selecting for broad host range bacteriophages. Front Microbiol 7(1352):1–6
Shivu MM, Rajeeva BC, Girisha SK, Karunasagar I, Krohne G, Karunasagar I (2007) Molecular characterization of Vibrio harveyi bacteriophages isolated from aquaculture environments along the coast of India. Environ Microbiol 9(2): 322–331, 2007
Skurnik M, Strauch E (2006) Phage therapy: facts and fiction. Int J Med Microbiol 296:5–14
Stomps CC, Hoj L, Bourne DG, Hall MR, Owens L (2010) Isolation of lytic bacteriophage against Vibrio harveyi. J Appl Micro 108:1744–1750
Subharthi P (2015) Phage therapy an alternate disease control in aquaculture: a review on recent advancements. IOSR J Agric Vet Sci 8(9):68–81
Sugumar G, Nakai T, Hirata Y, Matsubara D, Muroga K (1998) Vibrio splendidus biovar II as the causative agent of bacillary necrosis of Japanese oyster Crassostrea gigas larvae. Dis Aquat Org 33:111–118
Sulakvelidze A, Alavidze Z, Morris Jr JG (2001) Bacteriophage therapy. Antimicrob. Agents Chemother 45: 649–659
Tang SS, Biswas SK, Tan WS, Saha AK, Leo BF (2019) Efficacy and potential of phage therapy against multidrug resistant Shigella spp. Peer J 7:e6225
Verner-Jeffreys DW, Algoet M, Pond MJ, Virdee HK, Bagwell NJ, Roberts EG (2007) Furunculosis in Atlantic salmon (Salmo salar L.) is not readily controllable by bacteriophage therapy. Aquaculture 270(1–4):475–484
Vinod MG, Shivu MM, Umesha KR, Rajeeva BC, Krohne G, Karunasagar I, Karunasagar I (2006) Isolation of Vibrio harveyi bacteriophage with a potential for biocontrol of luminous vibriosis in hatchery environments. Aquaculture 255:117–124. https://doi.org/10.1016/j.aquaculture.2005.12.003
Wang Y, Bartn M, Elliott L, Li X, Abraham S, Dae MO, Munr J (2017) Bacteriophage therapy for the control of Vibrio harveyi in greenlip abalone (Haliotis laevigata). Aquaculture 473:251–258
Wittebole X, De Roock S, Opal SM (2014) A historical overview of bacteriophage therapy as an alternative to antibiotics for the treatment of bacterial pathogens. Virulence 5:226–235
Wu JL, Chao WJ (1982) Isolation and application of a new bacteriophage, ET-1, which infect Edwardsiella tarda, the pathogen of edwardsiellosis, Rep Fish Dis Res IV (8): 8–17
Wu JL, Lin HM, Jan L, HSU YL, Chang LH (1981) Biological control of fish bacterial pathogen, Aeromonas hydrophila, by bacteriophage AH1. Fish Pathol 15:271–276
Young R, Wang IN, Roof WD (2000) Phages will out strategies of host cell lysis. Trends Microbiol 8:120–128
Funding
The University Grants Commission, New Delhi, provided research grant and support to SS and PR. GSK received research grant from DBT.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Ethical approval
This article does not contain any studies with animals performed by anyof the authors.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Ninawe, A.S., Sivasankari, S., Ramasamy, P. et al. Bacteriophages for aquaculture disease control. Aquacult Int 28, 1925–1938 (2020). https://doi.org/10.1007/s10499-020-00567-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10499-020-00567-4